Meibang Corporation: Abnormal stock price fluctuations, declining performance and deviation from gains suggest risk.

Meiban Corporation announced that the company's stock experienced abnormal fluctuations as the closing prices on February 12, 13, and 24, 2026 deviated by over 20% for three consecutive trading days. In the first three quarters of 2025, the company achieved a revenue of 609 million yuan, a year-on-year decrease of 2.23%, and a net profit of 36.1961 million yuan, a year-on-year decrease of 16.36%. From February 10th to 24th, the company's stock closed at the limit-up for four consecutive days, with a cumulative increase of 46.43%, higher than the Shanghai Stock Index and the "Agricultural Chemical Products" industry during the same period. The company's latest rolling price-earnings ratio was 143.19, higher than the industry's 33.99. The company reminds investors to pay attention to risks such as stock prices, performance, and price-earnings ratios.